BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6337094)

  • 1. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
    Kaijser B; Larsson P; Olling S; Schneerson R
    Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
    Kaijser B; Larsson P; Olling S
    Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
    Straube E; Nimmich W; Broschewitz U; Naumann G
    Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunization with Escherichia coli K1 antigen on the course of experimental infection of the urinary tract of the rat.
    Straube E; Nimmich W; Broschewitz U; Naumann G; Hacker K
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):408-19. PubMed ID: 3314264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.
    Kumar V; Ganguly Nk; Joshi K; Mittal R; Harjai K; Chhibber S; Sharma S
    Med Microbiol Immunol; 2005 Aug; 194(4):211-7. PubMed ID: 15909203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
    Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
    Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Escherichia coli K and O antigens in protection against acute pyelonephritis.
    Kaijser B; Larsson P; Nimmich W; Söderström T
    Prog Allergy; 1983; 33():275-88. PubMed ID: 6187016
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
    Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
    Infection; 1985; 13 Suppl 2():S256-9. PubMed ID: 3902658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
    Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
    Infection; 1984; 12(4):309-12. PubMed ID: 6386695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Escherichia coli ascending pyelonephritis in rats: changes in bacterial properties and the immune response to surface antigens.
    Mattsby-Baltzer I; Hanson LA; Kaijser B; Larsson P; Olling S; Svanborg-Edén C
    Infect Immun; 1982 Feb; 35(2):639-46. PubMed ID: 7035369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification by cyclophosphamide of the effect of autovaccination in chronic pyelonephritis in an animal experiment].
    Straube E; Broschewitz U; Nimmich W; Naumann G; Hacker K
    Z Urol Nephrol; 1987 Jun; 80(6):353-63. PubMed ID: 3307215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
    Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
    J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
    J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipili antibody affords protection against experimental ascending pyelonephritis.
    Silverblatt FJ; Cohen LS
    J Clin Invest; 1979 Jul; 64(1):333-6. PubMed ID: 376560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
    Smith JW; Kaijser B
    J Clin Invest; 1976 Aug; 58(2):276-81. PubMed ID: 783196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathogenesis of pyelonephritis].
    Golokolosov AS
    Pediatriia; 1972 Oct; 51(10):78-82. PubMed ID: 4581200
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.
    Björkstén B; Kaijser B
    Infect Immun; 1978 Nov; 22(2):308-11. PubMed ID: 365753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.